REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Valueadd Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Packaging and Labeling Services
Full name: Valueadd Pharma Sp. z o.o. Profile Updated: May 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Valueadd Pharma Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on March 03, 2017. A growth of 8.33% was recorded in its total assets.

Headquarters
Ul. Domaniewska 47/10
Warsaw; Mazowieckie; Postal Code: 02-672

Contact Details: Purchase the Valueadd Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Valueadd Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Valueadd Pharma Sp. z o.o. report to view the information.
Incorporation Date:
March 03, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Valueadd Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-1.96%▼
Total assets
8.33%▲
Total equity
8.33%▲

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Windprojekt Sp. z o.o.
 
Wilandt Institute
Wet-Family Sp. z o.o.
 
Wekzmed Sp. z o.o.
Warsaw Genomics Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo